Correlation Between Warteck Invest and Relief Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Warteck Invest and Relief Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Warteck Invest and Relief Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Warteck Invest and Relief Therapeutics Holding, you can compare the effects of market volatilities on Warteck Invest and Relief Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Warteck Invest with a short position of Relief Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Warteck Invest and Relief Therapeutics.

Diversification Opportunities for Warteck Invest and Relief Therapeutics

0.67
  Correlation Coefficient

Poor diversification

The 3 months correlation between Warteck and Relief is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Warteck Invest and Relief Therapeutics Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Relief Therapeutics and Warteck Invest is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Warteck Invest are associated (or correlated) with Relief Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Relief Therapeutics has no effect on the direction of Warteck Invest i.e., Warteck Invest and Relief Therapeutics go up and down completely randomly.

Pair Corralation between Warteck Invest and Relief Therapeutics

Assuming the 90 days trading horizon Warteck Invest is expected to generate 24.75 times less return on investment than Relief Therapeutics. But when comparing it to its historical volatility, Warteck Invest is 20.76 times less risky than Relief Therapeutics. It trades about 0.14 of its potential returns per unit of risk. Relief Therapeutics Holding is currently generating about 0.17 of returns per unit of risk over similar time horizon. If you would invest  183.00  in Relief Therapeutics Holding on September 4, 2024 and sell it today you would earn a total of  253.00  from holding Relief Therapeutics Holding or generate 138.25% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy98.46%
ValuesDaily Returns

Warteck Invest  vs.  Relief Therapeutics Holding

 Performance 
       Timeline  
Warteck Invest 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Warteck Invest are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, Warteck Invest is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
Relief Therapeutics 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Relief Therapeutics Holding are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal technical and fundamental indicators, Relief Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Warteck Invest and Relief Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Warteck Invest and Relief Therapeutics

The main advantage of trading using opposite Warteck Invest and Relief Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Warteck Invest position performs unexpectedly, Relief Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Relief Therapeutics will offset losses from the drop in Relief Therapeutics' long position.
The idea behind Warteck Invest and Relief Therapeutics Holding pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Complementary Tools

Equity Valuation
Check real value of public entities based on technical and fundamental data
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance